In:
International Journal of Cancer, Wiley, Vol. 145, No. 8 ( 2019-10-15), p. 2238-2248
Abstract:
What's new? Treatment options for malignant mesothelioma (MM) have not significantly improved over the past four decades. A better understanding of the immune response in MM might guide new treatment strategies. In this study, the authors found evidence that natural killer (NK) cells can infiltrate, recognize, and kill MM cells. However, MM patients have distinct alterations in NK, CD8 + T‐cell, and cytokine profiles. Some of these alterations correlated with prognosis, or were affected by treatment with tremelimumab.
Type of Medium:
Online Resource
ISSN:
0020-7136
,
1097-0215
Language:
English
Publisher:
Wiley
Publication Date:
2019
detail.hit.zdb_id:
218257-9
detail.hit.zdb_id:
1474822-8
Permalink